The hepatitis C virus (HCV) is a major public health problem and a leading cause of chronic liver disease. In the United States, the Centers for Disease Control and Prevention estimates that there are more than 2.7 million people with ongoing HCV infection. HCV is the leading cause of death from liver disease in the United States. We need to have clinicians with approaches to the diagnosis, management, and prevention of HCV infection. Medical management course for doctors is a thing that should be concerned and well updated. With good program to teach the teacher course for doctors.
The optimal methods of detecting HC V infection are to screen populations for history of risk and to test selected individuals with an identifiable risk factor. we can know all of symptoms at spr medical management course for doctors. With careful questioning, an HCV risk factor can be identified in more than 90% of cases. The primary source of HCV transmission is HCV infected blood or blood products. In the United States, injection drug use is the chief mode of transmission, and anyone who has ever injected illicit drugs should be tested. Persons should also be tested if they received a blood or blood component transfusion or organ transplant before 1992,when sensitive tests were first used to screen donors for HCV antibodies. Since that time, HCV infection is rarely transmitted by transfusion.
Other potential sources of HCV transmission include exposure to an infected sexual partner or multiple sexual partners, frequent exposure to infected blood among health care workers, and perinatal exposure.
Persons found to be HCV-infected need to be counseled regarding prevention of spread of the virus to others.
Good clinical practice dictates that all persons identified as infected with HCV be informed that transmission to others occurs through contact with their blood and that they should there fore take precautions against the possibility of such exposure. Although this advice applies to all HCV-infected persons,it has particular importance for injection drug users who are the leading source of HCV infections.
